KATY BRIGGS: Open Payments
NPI 1265447007 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,365 in 60 payments from 15 companies in 2025. Trend: 2023 $1,149 · 2024 $2,768 · 2025 $1,365
Food & beverage: $1,365
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $308 |
| GlaxoSmithKline, LLC. | 12 | $213 |
| JAZZ PHARMACEUTICALS INC. | 7 | $189 |
| HARMONY BIOSCIENCES LLC | 5 | $158 |
| Axsome Therapeutics, Inc. | 3 | $89 |
| Amgen Inc. | 4 | $88 |
| Lilly USA, LLC | 3 | $60 |
| Actelion Pharmaceuticals US, Inc. | 2 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $43 |
| 3B Medical, Inc. | 2 | $38 |
Products named: TEZSPIRE, XYWAV, FASENRA, WAKIX, NUCALA, Sunosi, DUPIXENT, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
